Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $23,551,110 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 150 grants at over 100 hospitals in 17 countries.
![](/media/gpjhvnyf/lu.jpg)
Cincinnati Children's Hospital – $200,000
$200,000.00
November 2023
Targeting diffuse midline gliomas with innovative T cell immunotherapy
![](/media/4445/biplab-dasgupta.jpg)
Cincinnati Children's Hospital – $50,000
$50,000.00
May 2023
Exploring Novel Targets In DIPG
![](/media/xtxp015a/maria-wiese.jpg)
University Medicine Göttingen – $50,000
$50,000.00
May 2023
Starve the monster: Multi-metabolic treatment strategies for H3.3K27M-mutant DIPG/DMG
![](/media/3781/pbtc-logo.png)
Funding of PBTCF 2023 - $25,000
$25,000.00
January 2023
![](/media/4486/genovesi.jpeg)
University of Queensland Diamantina Institute – $100,000
$100,000.00
November 2022
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma
![](/media/ddept4sd/zanten2.jpg)
Erasmus University Medical Center – $432,354
$432,354.00
November 2022
Development and optimization of targeted radiopharmaceutical therapies for pediatric brain tumors; a world-first translational study. Acronym: TARGET-FIRST
![](/media/gpjhvnyf/lu.jpg)
Cincinnati Children's Hospital Medical Center – $60,000
$60,000.00
November 2022
Targeting Histone Lysine Demethylases to Treat Diffuse Intrinsic Pontine Glioma
![](/media/gpjhvnyf/lu.jpg)
Cincinnati Children's Hospital Medical Center – $153,867
$153,867.00
November 2022
Combining innovative proton radiotherapy with targeted and immune therapies to treat DMG/DIPG
![](/media/3604/matthew-dun.jpg)
Hunter Medical Research Institute – $232,932
$232,932.00
November 2022
Enhancing the recruitment of tumor infiltrating lymphocytes to improve responses to DMG therapies
![](/media/ybtazxd2/marcus.jpg)
SONALASENSE – $198,436
$198,436.00
November 2022
A Phase 1/2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2 in Patients With DIPG
![](/media/4455/pollack-ian.jpg)
UPMC Childrens Hospital of Pittsburgh – $100,000
$100,000.00
November 2022
The Role of QPRT and NAD Pathways in DIPG Treatment Resistance (Continued)
![](/media/3140/cynthia_hawkins.jpg)
The Hospital For Sick Children (SickKids) – $100,000
$100,000.00
November 2022
Synthetic lethality screening with methionine restriction for treatment of DIPG
![](/media/ml2f5hhk/gomez-manzano.jpg)
University of Texas MD Anderson Cancer Center – $100,000
$100,000.00
November 2022
Viroimmunotherapy for pediatric brain tumors
![](/media/4pvck5gj/duchatel.jpg)
Hunter Medical Research Institute – $200,000
$200,000.00
November 2022
DMG COMBATT 2.0: Diffuse Midline Glioma COMbined Anti-Tumor Targeting 2.0
![](/media/3096/jones_chris.jpg)
The Institute of Cancer Research – $501,183
$501,183.00
November 2022
Translating Mechanism to Patient Benefit for ACVR1-Mutant Diffuse Intrinsic Pontine Glioma (DIPG)